Skip to main content

Advertisement

Log in

Generation and delivery of “Yamanaka factor” recombinant proteins mediated with magnetic iron oxide nanoparticles (MIONPs)

  • Original Article
  • Published:
Applied Nanoscience Aims and scope Submit manuscript

Abstract

Reprogramming mediated with proteins provides a novel, simpler, and safer strategy for generating induced pluripotent stem cells (iPSCs); in order to efficiently produce the recombination proteins and optimize the gene delivery system, different agents were screened to efficiently transfect plasmid DNA (pDNA) encoding “Yamanaka factor” (Oct 4, Sox 2, Klf 4, or c-Myc) into human embryonic kidney (HEK)-293T cells. The results indicated that 10 μg/mL Poly-MAG (polyethyleneimine (PEI)-MIONP) combined with exogenous magnetic field, 5 μg/mL Lipofectamine® 2000, and 40 μg/mL PEI were, respectively, more suitable to deliver the pDNA encoding Oct 4 into HEK-293T cells in the same transfection reagent groups, but the cell survival rate in 10 μg/mL Poly-MAG treatment group was significantly higher than that in the latter two groups (P < 0.01). “Yamanaka factor” recombination proteins could be extracted and purified from enhanced green fluorescent protein positive (EGFP+) HEK-293T cells. These recombination proteins could be delivered into fibroblasts of miniature pig via the actions of poly-arginine 9R, Poly-MAG, and exogenous magnetic field, producing iPSC-like cells. Furthermore, these iPSC-like cells with MIONPs would be enriched under the action of magnetic force. Therefore, the synergistic action of Poly-MAG and exogenous magnetic field could not only mediate the gene delivery of “Yamanaka factor”, but also enhance the transmembrane of functional recombination proteins and enrichment of generated iPSC-like cells, which laid a solid foundation for future safer iPSC-based targeted therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (Grant No. 31572488), the Based and Advanced Research Projects of Chongqing (Grant No. cstc2017jcyjAX0477), and Chongqing Technological Innovation and Application Demonstration for Social and Livelihood Development (Grant No. cstc2018jscx-msyb0796).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xiong Xiao or Xiaoyan Qiu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standards

The manuscript does not contain clinical studies or patient data.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xiao, X., Zhang, D., Wang, M. et al. Generation and delivery of “Yamanaka factor” recombinant proteins mediated with magnetic iron oxide nanoparticles (MIONPs). Appl Nanosci 10, 1757–1770 (2020). https://doi.org/10.1007/s13204-020-01257-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13204-020-01257-6

Keywords

Navigation